Founded 2011, London-based (formerly Hambro Perks, est. 2013). Portfolio of 144 companies across equity, debt & secondary. 40-person team incl. 18 partners. Notable exits: Lindus Health (clinical trials, Series B); Fintern (fintech, 332% CAGR); Moneybox (savings/investing, 1M+ customers). Value: operational support, fundraising expertise, co-invests with 500 Global.
Investment Focus
Investment Thesis
Early stage (primarily seed stage) investments in technology/tech-enabled companies. Top sectors: Enterprise Applications (68 investments), FinTech (38 investments). Invests primarily in UK & US. Multi-fund platform incl. Oryx Fund for pre-seed/seed MENA tech. Offers early/late-stage equity, secondary investments & growth debt. Ranked 5th VC, avg CAGR 296%. Value-add: active portfolio management, global network.
Interested in connecting?
Visit their website or reach out directly.